Proton Therapy for Chordomas and/or Chondrosarcomas

Clinical Trial Description

Data collection will be obtained from the patient's medical records including initial evaluation, pathology report, dosimetry information, radiotherapy completion records and follow-up. ;

Study Design

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02389244` - A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas	Phase 2
Completed	`NCT00401388` - A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas	Phase 2
Active, not recruiting	`NCT01449149` - Proton Radiation for Chordomas and Chondrosarcomas	N/A

See also

Status

Clinical Trial

Phase

Recruiting

NCT02389244 - A Phase II Study Evaluating Efficacy and Safety of Regorafenib in Patients With Metastatic Bone Sarcomas

Phase 2

Completed

NCT00401388 - A Trial of Perifosine in Patients With Chemo-Insensitive Sarcomas

Phase 2

Active, not recruiting

NCT01449149 - Proton Radiation for Chordomas and Chondrosarcomas

N/A

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT00797602
Study type	Observational
Source	University of Florida
Contact
Status	Completed
Phase	N/A
Start date	January 2007
Completion date	December 2015

Proton Therapy for Chordomas and/or Chondrosarcomas — CH01

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms